Beximco Pharma Wins International Award

[Bilal9]

4 December, 2017 12:46:38 AM / LAST MODIFIED: 4 December, 2017 08:17:02 AM
http://www.theindependentbd.com/home/printnews/126524
STAFF REPORTER
Beximco Pharma has won the prestigious Scrip Award in the category of ‘Best Company in an Emerging Market’ at the 13th Annual Scrip Awards ceremony held in London recently. Rabbur Reza, chief operating officer of Beximco Pharma, accepted the award on behalf of the company.

Beximco Pharma has won the prestigious Scrip Award in the category of ’Best Company in an Emerging Market’ at the 13th Annual Scrip Awards ceremony held in London recently. Rabbur Reza, Chief Operating Officer of Beximco Pharma, accepted the award on behalf of the company, according to a press release issued yesterday. This is the first time a Bangladeshi company has won this global award which recognizes company’s operational excellence and continued growth in global market, it said. The Scrip Awards honor the highest achieving companies and individuals in global pharma and biotech industry, recognizing their important roles in improving healthcare around the world. A panel of 16 highly respected and independent judges from across diverse sectors evaluated the award entries to select the finalists.

Scrip’s Best Company in an Emerging Market Award seeks to reward the growing R&D-based pharmaceutical company founded in areas beyond its traditional geographic borders of North America, Western Europe and Japan. Previous winners in this category include globally reputed pharma companies like Dr Reddy’s, Hikma, Glenmark and Mundipharma.

On this occasion, Beximco Pharma Managing Director Nazmul Hassan MP said, “We are proud to be recognized as the ‘Best Company in an Emerging Market’ at the prestigious Scrip Awards. With its broad portfolio of generics and global footprint in more than 50 countries including US, EU and Australia, Beximco Pharma is continuing to expand its reach and impact around the world. We are setting a high standard for the country’s pharmaceutical industry through our research and development initiatives, strategic partnerships, and expansion programs.”

 

[bd_4_ever]

Congrats to Beximco!

 

[Bilal9]

Beximco Pharma commenced its second product export to the US

Beximco Pharmaceuticals Limited ("BPL", "Beximco Pharma" or "Company"; AIM Symbol: BXP), the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, today announced it has commenced the export of Sotalol Hydrochloride (80 mg, 120 mg and 160 mg), a generic version of the cardiovascular drug Betapace, to the US. Following the successful launch of Carvedilol to the US in August 2016, this is the second product from Beximco Pharma to be exported to the US.

According to QuintlesIMS data, the market size for Satalol Hydrochloride (including all strengths) in the US is $23 million. The first consignment was delivered on 29 October 2017 and the product will be distributed through the Company’s existing partner in the US.

Managing Director of Beximco Pharma, Mr. Nazmul Hassan MP commented:
“We are delighted to strengthen our presence in the US with the launch of our second product in this market. With the export of our first product to the US in August 2016, we began a new era for the pharmaceutical industry in Bangladesh that we continue to build with the launch of Sotalol. This is a validation of our expertise in offering specialised generic products in a global setting. With our growing pipeline for the US, we will focus on increasing our presence in the world’s largest pharma market in the coming years.”

In June 2015, Beximco Pharma became the first Bangladeshi pharmaceutical company audited and approved by the US Food and Drug Administration (FDA). Since then - other companies in Bangladesh have been approved as well.

Beximco Pharma is one of the largest exporters of pharmaceuticals in Bangladesh, winning the country’s National Export Trophy (Gold) a record five times, the highest national accolade for export. The Company currently has a global footprint in more than 50 countries and has been accredited by a number of global regulatory authorities, including US FDA, AGES, Austria (EU), TGA Australia, Health Canada, GCC and TFDA.


Company Seniors and Finance Minister with the US Ambassador at the inauguration ceremony

 

[idune]

Beximco Pharma sure is a good icon of Bangladesh but same can not be said its out right thief (majority) owners. If this company was and is owned by different people Beximco would have been much prominent than what it is today.

 

[Bilal9]

Beximco Pharma sure is a good icon of Bangladesh but same can not be said its out right thief (majority) owners. If this company was and is owned by different people Beximco would have been much prominent than what it is today.

You are absolutely right, their banking arm has severe irregularities, but Pharma, Textile and Ceramics are run by professional managers as I have seen.

At least the managers that run their group companies are professional enough.